NCT06553482

Brief Summary

Exercise is an essential pillar for the health of all individuals, as it contributes to physical, mental, and emotional well-being. Various international organizations, such as the World Health Organization, advocate for the integration of exercise into healthy lifestyles, recognizing its im-portance in disease prevention and improving quality of life. However, despite the general consensus on its value, there is no universal agreement on specific prescriptions for vulnerable groups, highlighting the need for personalized approaches that consider the unique characteristics and needs of each individual. It has been proposed that a moderate aerobic exercise training program could promote positive outcomes in individuals living with overweight and obesity, particularly with an emphasis on reducing injury risk, ensuring high adherence, and achieving favorable health changes. In this regard, the present protocol establishes the basis for a randomized clinical trial based on exercise prescription at the maximal fat oxidation rate in young individuals with overweight and obesity, with a duration of 16 weeks. Throughout the study, biochemical changes (cholesterol, glucose, triglycerides, and inflammatory markers), metabolic changes (de-termination of fat and carbohydrate utilization rates during rest and exercise), and epigenetic changes (focusing on microRNAs associated with adipogenesis, inflammation, and fat metabolism) will be monitored.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Jan 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2025Jan 2027

First Submitted

Initial submission to the registry

August 11, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 14, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

August 15, 2024

Status Verified

August 1, 2024

Enrollment Period

1.6 years

First QC Date

August 11, 2024

Last Update Submit

August 13, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Body composition change

    Changes in body composition (fat mass and muscle mass) after the intervention

    16 weeks

Secondary Outcomes (2)

  • Changes in lipid profile

    16 weeks

  • Changes in epigenetic markers

    16 weeks

Study Arms (3)

FatMax group

EXPERIMENTAL

low-intensity exercise training sessions (FatMax zone)

Other: FatMAx training intervention

FatMAx and musuclar endurance exercise group

EXPERIMENTAL

FatMax zone exercises as well as muscular resistance exercises

Other: FatMax and physical endurance exercise intervention

Control

ACTIVE COMPARATOR

Group without physical activity intervention

Other: Control

Interventions

FatMax training program on a treadmill or stationary bicycle, whichever is more convenient for them

FatMax group

FatMax training program on a treadmill or stationary bicycle, whichever is more convenient for them, with muscular endurance exercise

FatMAx and musuclar endurance exercise group
ControlOTHER

No intervention pf physical activity

Control

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Both genders
  • Daily energy expenditure \<4 METs
  • Body mass index ≥25 kg/m2
  • Acceptance of informed consent
  • ≥100 ml of alcohol consumption per week
  • Consume a dietary supplement or pharmacological treatment
  • Have limitations to perform regular physical activity
  • Have a chronic non-communicable disease
  • Answer "yes" to any of the questions on the Physical Activity Readiness- Questionnaire for Everyone (PAR-Q+); which represents a health risk.
  • \<80% attendance at exercise sessions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical and Psychology School

Tijuana, California, 22390, Mexico

Location

Related Publications (6)

  • Chavez-Guevara IA, Urquidez-Romero R, Perez-Leon JA, Gonzalez-Rodriguez E, Moreno-Brito V, Ramos-Jimenez A. Chronic Effect of Fatmax Training on Body Weight, Fat Mass, and Cardiorespiratory Fitness in Obese Subjects: A Meta-Analysis of Randomized Clinical Trials. Int J Environ Res Public Health. 2020 Oct 28;17(21):7888. doi: 10.3390/ijerph17217888.

    PMID: 33126461BACKGROUND
  • Brun JF, Myzia J, Varlet-Marie E, Raynaud de Mauverger E, Mercier J. Beyond the Calorie Paradigm: Taking into Account in Practice the Balance of Fat and Carbohydrate Oxidation during Exercise? Nutrients. 2022 Apr 12;14(8):1605. doi: 10.3390/nu14081605.

    PMID: 35458167BACKGROUND
  • Pico-Sirvent I, Manresa-Rocamora A, Aracil-Marco A, Moya-Ramon M. A Combination of Aerobic Exercise at Fatmax and Low Resistance Training Increases Fat Oxidation and Maintains Muscle Mass, in Women Waiting for Bariatric Surgery. Obes Surg. 2022 Apr;32(4):1130-1140. doi: 10.1007/s11695-022-05897-1. Epub 2022 Jan 20.

    PMID: 35048250BACKGROUND
  • Chavez-Guevara IA, Amaro-Gahete FJ, Ramos-Jimenez A, Brun JF. Toward Exercise Guidelines for Optimizing Fat Oxidation During Exercise in Obesity: A Systematic Review and Meta-Regression. Sports Med. 2023 Dec;53(12):2399-2416. doi: 10.1007/s40279-023-01897-y. Epub 2023 Aug 16.

    PMID: 37584843BACKGROUND
  • Wang D, Zhang P, Li J. Crossover point and maximal fat oxidation training effects on blood lipid metabolism in young overweight women: a pilot study. Front Physiol. 2023 Jun 16;14:1190109. doi: 10.3389/fphys.2023.1190109. eCollection 2023.

    PMID: 37398909BACKGROUND
  • Hernandez-Lepe MA, Hernandez-Ontiveros DA, Chavez-Guevara IA, Ramos-Jimenez A, Hernandez-Torres RP, Lopez-Fregoso RJ, Ramos-Lopez O, Amaro-Gahete FJ, Muniz-Salazar R, Olivas-Aguirre FJ. Impact of Exercise Training at Maximal Fat Oxidation Intensity on Metabolic and Epigenetic Parameters in Patients with Overweight and Obesity: Study Protocol of a Randomized Controlled Trial. J Funct Morphol Kinesiol. 2024 Oct 31;9(4):214. doi: 10.3390/jfmk9040214.

MeSH Terms

Conditions

OverweightObesityBody Weight Changes

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • René Bassó-Quevedo, MSc

    Bioethic Comittee of the Autonomous University of Baja California

    STUDY CHAIR

Central Study Contacts

María G. Delgadillo-Ramos, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Statistical Analysis will be conducted without knowledge of gropus allocation.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The subjects assigned to each group will participate in a randomized clinical trial, with a duration of 16 weeks of intervention. Measurements of all variables will be taken on the first day of the evaluation (considered the basal state) and at the end of 16 weeks of the intervention according to the group in which they were randomized, to be followed by sta-tistical analysis of the data. The variables contemplated involve assessments of body composition and physical capacities, biochemical variables, epigenetic variables and alternate variables.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 11, 2024

First Posted

August 14, 2024

Study Start

January 1, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

August 15, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Publication of manuscripts without any name of a participant

Locations